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Introduction
Controversies regarding control of endemic methicillin-
resistant Staphylococcus aureus (MRSA) stem in part
from the paucity of data available on the actual costs of
implementing MRSA control strategies.
Objectives
To estimate the workloads associated with screening and
hand hygiene (HH) promotion interventions for MRSA
control.
Methods
Prospective evaluation of costs associated with MRSA
control interventions, alongside the MOSAR–Surgery
multicenter intervention trial [1], emphasizing the work-
loads associated with interventions. Interventions under
study were (1) universal MRSA screening with contact
precautions and decolonization (4 hospitals) and (2)
enhanced HH promotion (4 hospitals); 2 hospitals imple-
mented a combined strategy using targeted MRSA
screening.
Workloads were estimated from a hospital perspective,
using a top-down approach, distinguishing infection
control (IC) and ward staff duties, set-up and routine
activities, and excluding research-driven tasks.
Results
In the screening arm (13 wards; mean, 27.8 ± 10.4 beds),
set-up required 2.6 ± 0.58 weeks of work from the IC
team, and the mean annual workload was 20.5 weeks
or 8.62 ± 4.39 weeks for a 10-bed ward. In the HH
promotion arm (13 wards, 87.8 ± 79.5 beds), set-up
required 2.77 ± 1.13 weeks, and mean annual workload
was 12.1 weeks (3.29 ± 3.72 per 10 beds). In the combined
arm (7 wards, 44.9 ± 24.6 beds), set-up required 7.0 ± 1.93
weeks, and mean annual workload was 23.7 weeks (5.94 ±
1.84 weeks per 10 beds). The burden on ward staff was
relatively limited in most wards.
Conclusion
Workload associated with the MRSA screening strategy is
relatively homogenous and predictable. Investment in the
HH promotion strategy showed large variations between
centers and was maximal for the successful combined
intervention. Further research is needed on the optimal
implementation of HH promotion interventions.
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